BAYLOR COLLEGE OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1900-10-30

Employees: 10K

Market Cap: -

Website: http://www.bcm.edu

Clinical Trials

Monoclonal Antibody Conditioning for Allogeneic Stem Cell Transplantation of Patients With Inherited Metabolic Storage Diseases

Phase 1

Terminated

Conditions: Inherited Metabolic Storage Diseases

Interventions: Drug: CAMPATH-1H
Drug: Anti-CD45
Drug: FK506
Drug: Fludarabine

First Posted Date: 2003-03-27

Last Posted Date: 2015-09-23

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 2

Registration Number: NCT00056979

Locations: 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸
The Methodist Hospital, Houston, Texas, United States

Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H

Phase 1

Completed

Conditions: Myelodysplastic Disorders
Leukemia
Multiple Myeloma
Plasma Cell Dyscrasia
Lymphoproliferative Disorders

First Posted Date: 2002-11-01

Last Posted Date: 2020-01-18

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 40

Registration Number: NCT00048412

Locations: 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸
The Methodist Hospital, Houston, Texas, United States

Stem Cell Transplantation for Patients With Graft Failure Following an Allogeneic Transplant, Using Identical or Near Identical Donors and Less Toxic Conditioning With CAMPATH 1H

Phase 1

Terminated

Conditions: Graft Failure

First Posted Date: 2002-11-01

Last Posted Date: 2020-01-18

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 40

Registration Number: NCT00048399

Locations: 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸
The Methodist Hospital, Houston, Texas, United States

Treatment of Resistant Langerhans Cell Histiocytosis With ENBREL

Phase 2

Completed

Conditions: Histiocytosis, Langerhans-Cell

First Posted Date: 2002-11-01

Last Posted Date: 2020-01-09

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 20

Registration Number: NCT00048373

Locations: 🇺🇸
Texas Children's Hospital, Houston, Texas, United States

Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors

Not Applicable

Completed

Conditions: Brain Tumors

First Posted Date: 2002-08-01

Last Posted Date: 2020-03-04

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 119

Registration Number: NCT00042367

Locations: 🇺🇸
Brain Tumor Center at Duke University, Durham, North Carolina, United States
🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients

Phase 2

Completed

Conditions: Neoplasms

First Posted Date: 2002-08-01

Last Posted Date: 2015-08-24

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 30

Registration Number: NCT00042328

Locations: 🇺🇸
Texas Children's Hospital, Houston, Texas, United States

Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies

Phase 2

Terminated

Conditions: Sickle Cell Anemia
Hemoglobinopathy
Thalassemia

First Posted Date: 2002-06-28

Last Posted Date: 2020-01-18

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 15

Registration Number: NCT00040469

Locations: 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸
The Methodist Hospital, Houston, Texas, United States

Oral Magnesium Pidolate, Hemoglobin SC Disease, MG Pidolate

Phase 2

Terminated

Conditions: HEMOGLOBIN SC DISEASE

Interventions: Drug: Placebo
Drug: Mg Pidolate

First Posted Date: 2002-06-28

Last Posted Date: 2012-11-19

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 12

Registration Number: NCT00040456

Locations: 🇺🇸
Children's Hospital, Boston, Massachusetts, United States
🇺🇸
Texas Children's Hospital, Houston, Texas, United States

High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple Sclerosis

Phase 2

Completed

Conditions: Multiple Sclerosis

First Posted Date: 2002-06-28

Last Posted Date: 2020-01-18

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 10

Registration Number: NCT00040482

Locations: 🇺🇸
The Methodist Hospital, Houston, Texas, United States

Bone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With High Risk Hemoglobinopathies

Phase 2

Terminated

Conditions: Sickle Cell Anemia
Hemoglobinopathy
Thalassemia

First Posted Date: 2002-06-27

Last Posted Date: 2020-01-18

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 15

Registration Number: NCT00040417

Locations: 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸
The Methodist Hospital, Houston, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy